Deja Robinson

Long-Acting Drugs May Revolutionize H.I.V. Prevention and Treatment

Approved Medications Research / By

Long-acting injectable therapies like rilpivirine and cabotegravir have notably influenced HIV treatment. Administered every few months, these injections offer an alternative to daily oral medications, which may benefit patients who have difficulty with adherence. The article discusses the potential benefits of these therapies, including improved adherence and convenience, while also addressing challenges such as cost, […]

Long-Acting Drugs May Revolutionize H.I.V. Prevention and Treatment Read More »

Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies

Approved Medications Research / By

Emtricitabine/tenofovir disoproxil fumarate (F/TDF) oral pre-exposure prophylaxis (PrEP) has a strong efficacy against HIV-1 acquisition. In different settings, 72 prospective studies of daily oral F/TDF PrEP were carried out to assess the incidence of HIV-1, medication resistance, adherence, and bone and renal safety.

Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies Read More »

Innovative Team Approach to Sexual Health Counseling; Partnership of Urology, Infectious Disease and Pelvic Floor Therapy to Increase Access to Care

Apretude / By

Pre-exposure prophylaxis (PrEP) is one HIV preventive strategy that is widely used, yet AIDS cases still outnumber treatment and prevention attempts. Significant obstacles still exist, including stigma, prejudice, and lack of access, especially for vulnerable populations like women, minorities, and LGBTQ people. In order to address these problems through a comprehensive approach to sexual health

Innovative Team Approach to Sexual Health Counseling; Partnership of Urology, Infectious Disease and Pelvic Floor Therapy to Increase Access to Care Read More »

Long-acting Injectable PrEP Interest and General PrEP Awareness among People who Inject Drugs in the San Diego-Tijuana Border Metroplex

Approved Medications Research / By

This article examines interest in long-acting injectable pre-exposure prophylaxis (PrEP) and general PrEP awareness among people who inject drugs in the San Diego-Tijuana border region. The article discusses the need for targeted education and outreach to improve PrEP awareness and uptake in these communities. 

Long-acting Injectable PrEP Interest and General PrEP Awareness among People who Inject Drugs in the San Diego-Tijuana Border Metroplex Read More »

Evidence Suggest Long-Acting Injectables Game Changer for Adherence

Cabenuva / By

There is emerging evidence that long-acting injectable therapies, such as rilpivirine and cabotegravir, may offer significant benefits for people with HIV, especially those who struggle with adherence to daily oral medications. These injections, administered every few months, could improve adherence and provide a more convenient alternative to daily pills. The article highlights ongoing challenges, including

Evidence Suggest Long-Acting Injectables Game Changer for Adherence Read More »

Treatment and Prevention of HIV Infection: Recommendations From the International Antiviral Society-USA Panel

Apretude / By

Early diagnosis, consistent treatment, and patient education are extremely important in managing HIV and preventing its spread. The article discusses the updated guidelines for treating and preventing HIV infection, focusing on the latest recommendations for antiretroviral therapy and preventive measures like pre-exposure prophylaxis (PrEP). The article also outlines strategies to enhance adherence to these guidelines

Treatment and Prevention of HIV Infection: Recommendations From the International Antiviral Society-USA Panel Read More »

Scroll to Top